In the highly regulated world of the pharmaceutical industry, cleaning validation is a cornerstone of compliance. But beyond the process itself, it is above all the documentation that carries weight. The challenge is knowing which texts to consult, which guides to follow, and which references to rely on.

Here is a clear overview of the documents you need to know, covering regulatory requirements, technical guides, and industry best practices.

Regulatory foundations

EMA – GMP Annex 15

An essential reference in Europe. It specifies expectations for validations, including cleaning validations. It covers the concepts of reproducibility, worst-case strategy, acceptance criteria, and more.

→ View document

FDA – 21 CFR Part 211

The foundation of compliance on the American side. Cleaning is not covered in great depth, but requirements for cleanliness, documentation, and validation are clearly present.

→ View document

EMA – HBEL Guideline (Health-Based Exposure Limits)

This document introduces toxicology-based exposure thresholds for defining acceptable residue limits. It is at the heart of the modern validation approach.

→ View document

Essential technical guides

Regulations are important, but technical guides are even more valuable: they are full of concrete explanations, methodological details, and highly targeted points of attention.

PDA Technical Report 29: Points to Consider for Cleaning Validation

This is a foundational document that establishes the key principles of cleaning validation for pharmaceutical and related industries. Designed as a practical toolkit, it offers a structured, science-based approach for building, implementing, and maintaining a robust cleaning validation program.

It covers in particular:

  • Critical elements to consider when defining a cleaning strategy: product residues, cleaning agents, and microorganisms.
  • Determining acceptance limits based on toxicology, clinical data, and analytical detection thresholds.
  • Sampling methods (rinse, swab, visual) and associated best practices.
  • Initial validation, revalidation, product changes, and deviation management.
  • Clear guidance toward the application of Quality Risk Management (QRM).

→ View document

PDA Technical Report 49: Points to Consider for Biotechnology Cleaning Validation

PDA Technical Report 49 is a strategic guide specifically designed to address the unique challenges of cleaning in biotechnology. The annexes, particularly those on the different approaches for calculating shared equipment train surface areas, are well worth reading.

This document focuses on:

  • The specificities of biological residues (proteins, endotoxins, cells, DNA) and their behavior during cleaning.
  • Cross-contamination risks specific to multi-product biotech systems.
  • Risk-based approaches tailored to the particularities of biotech equipment.
  • Pragmatic validation criteria, with concrete examples of acceptance limits.
  • The importance of ongoing scientific evaluation of cleaning within a lifecycle logic.

→ View document

ISPE Guide: Cleaning Validation Lifecycle - Applications, Methods, & Controls

This guide is an essential reference for professionals involved in controlling cross-contamination risk. Built around the cleaning validation lifecycle, it offers a modern approach aligned with the principles of Quality Risk Management (QRM).

It provides concrete recommendations for:

  • Defining a cleaning validation strategy consistent with product criticality.
  • Selecting target residues, determining acceptance limits, and choosing sampling methods.
  • Implementing a scientific and pragmatic approach from initial design through maintenance activities.
  • Effectively integrating cleaning into the overall quality system.

→ View document

ISPE - Baseline Guide Vol 7: Risk-Based Manufacture of Pharma Products

The ISPE Risk-MaPP guide offers a structured approach for managing cross-contamination risk in multi-product sites, relying on PDE and the principles of Quality Risk Management.

→ View document

Other technical resources not to overlook

  • The Annex 15 guide by the A3P Cleaning Validation GIC — a comprehensive breakdown of Annex 15 by healthcare industry professionals.
  • ICH Q2(R2) – For the validation of analytical methods used in cleaning.
  • ICH Q14 – For the development and validation of analytical methods used in cleaning.
  • APIC Cleaning Validation Guide – Very practical, it helps structure a worst-case strategy and select critical products.
  • PIC/S PI 006 – This guide reflects inspectors' perspective on cleaning validation. Very useful for preparing your audits.
  • Destin LeBlanc's memos — Practical and impactful fact sheets on cleaning validation. Clear, concrete, and field-oriented, they cover key topics such as acceptance limits, visual inspection, PDE, and sampling.

Conclusion

Knowing how to clean is good. Proving that you did it correctly is essential. These documents form your regulatory and technical toolkit. Mastering them strengthens the robustness of your approach and helps avoid unpleasant surprises during inspections.

Hally draws on all the pharmaceutical industry's reference documents (ISPE, PDA, ICH, EMA, FDA…) and integrates regulatory and technical best practices directly into its features, delivering guided, structured, and automated compliance.

Back to blog